UT Southwestern trial tests targeted radiation for advanced kidney cancer complication

UT Southwestern reported on October 15, 2026, that a clinical trial evaluated a novel treatment strategy for patients with advanced kidney cancer involving a dangerous blood vessel complication. The trial examined targeted radiation directed at an inferior vena cava tumor thrombus, followed by surgical removal of the affected kidney. [1]

The condition occurs when a kidney cancer tumor grows directly into the inferior vena cava, which is the largest vein in the human body. UT Southwestern noted that this condition represents a potentially life-threatening complication that often requires extensive surgery and carries a high risk that the cancer will recur. [1]

The study included patients such as Diane Gentry, a 71-year-old retiree from Watauga, Texas, who received a diagnosis of stage 4 kidney cancer in 2015 after the tumor invaded her main vein. UT Southwestern conducted the trial to determine whether delivering precise radiation to the tumor thrombus prior to surgical intervention could improve outcomes for affected individuals. [1]